Charlie Heise, Associate Director, Bioprocess Strategy and Development at FUJIFILM Biotechnologies, delves into the importance of selecting the most suitable manufacturing strategy and how kojoX™, combined with our ApolloX™ technology, can streamline the process from cell line development to commercial production at 20K L scale.